Current Figures May Underestimate COVID-19 Mortality in Symptomatic Patients
Current mortality rate estimates for COVID-19 may not be representative of the actual death rate.
Emerging Diseases
Emerging Diseases
Live Update of COVID-19 Global Cases – Courtesy of John Hopkins University
Featured Article
Latest News
Workers at Risk for COVID-19 Exposure Can Access Online Training
The National Institutes of Health has launched a new website with educational resources for hospital employees, emergency first responders, and other workers at risk for exposure to COVID-19.
FDA Allows Use of COVID-19 Convalescent Plasma for Severely Ill Patients Under Emergency IND
Convalescent plasma, which is collected from patients who have recovered from COVID-19, contains antibodies to SARS-CoV-2, the virus that causes the disease.
Multiple-Dose Fosfomycin for Complicated UTIs
In cases of complicated urinary tract infections (UTI) treated with multiple-dose fosfomycin, clinical resolution occurred in 2 of 3 treatment episodes.
Update on REMS-Required Testing During COVID-19 Pandemic
For patients suspected of having COVID-19, undergoing REMS-required testing to obtain a medication may put others at risk.
Countries’ Mitigation Measures Crucial for Containing Spread of COVID-19
The effect of COVID-19 response in China shows that quarantine, social distancing, and isolation of infected persons can contain the epidemic in other countries.
FDA Issues Statement Regarding NSAID Use and COVID-19
The FDA has issued a statement regarding the use of nonsteroidal anti-inflammatory drugs (NSAIDS) in patients with coronavirus disease 2019 (COVID-19).
Phase 1 Study of Investigational mRNA Vaccine for COVID-19 Underway
A phase 1 clinical trial evaluating an investigational vaccine for protection against coronavirus disease 2019 (COVID-19) has been initiated at the Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle.
FDA: Thermo Fisher COVID-19 Test Gets Emergency Use Authorization
The FDA has issued an Emergency Use Authorization to Thermo Fisher for its TaqPath COVID-19 Combo Kit, a diagnostic test that detects nucleic acid from SARS-CoV-2, the virus that causes coronavirus disease 2019.
FDA Updates Policy to Increase COVID-19 Testing Capabilities
Similar to the action taken in New York State, states will be responsible for the tests developed and used by laboratories in their states.
Decreased Antibiotic Susceptibility of S pneumoniae Strains
Nasopharyngeal pneumococcal and acute otitis media isolates from children have exhibited reduced susceptibility to several antibiotic classes after the introduction of PCV-13.
Mental Health Concerns Arise Amid COVID-19 Epidemic
The COVID-19 epidemic has underscored potential gaps in mental health services during emergencies, while also testing the resilience of healthcare workers and medical systems.
Pipeline: Investigational Therapies for COVID-19
Currently, there are no antivirals licensed by the FDA to treat patients with COVID-19.
COVID-19 in Chronic Lung Disease: What You Need to Know
We spoke with the founding director of the Center for Pulmonary Infection Research and Treatment, Charles Dela Cruz, MD, PhD, of Yale University to get a better understanding of the risks that COVID-19 may pose to patients with chronic lung disease.
Vancomycin for Acute Bacterial Skin and Skin Structure Infection
Using oral antibiotics when possible and limiting the durations of vancomycin treatment may decrease vancomycin-associated acute kidney injury in patients with acute bacterial skin and skin structure infections.
FDA, FTC Crack Down on Fraudulent COVID-19 “Treatments”
Warning letters issued by the FDA and the Federal Trade Commission (FTC) have been sent to several companies selling fraudulent products claiming to treat or prevent coronavirus 2019 (COVID-19).
COVID-19 Preparation Recommendations From the COPD Foundation
The COPD Foundation released practical recommendations for patients living with COPD who may have concerns about COVID-19.
Pneumonia Mortality Not Improved With Empiric Anti-MRSA Therapy
Anti-methicillin-resistant Staphylococcus aureus (MRSA) therapy in addition to standard pneumonia therapy does not improve mortality.
CDC Updates Guidance on Evaluating, Testing for COVID-19 as More Tests Become Available
The Centers for Disease Control and Prevention has updated the guidance for evaluation of persons under investigation for coronavirus disease 2019 (COVID-19), expanding the criteria to a wider group of symptomatic patients.
Effective Contact Tracing and Isolation May Help Control COVID-19 Outbreak
Highly effective contact tracing and isolation may be viable containment strategies for a COVID-19.
FDA Authorizes Emergency Use of Certain Respirators for HCPs During COVID-19 Outbreak
More respirators, including certain N95 masks, will be made available to healthcare personnel, according to the FDA and the CDC.
Want to read more?
Please login or register first to view this content.
Next post in Emerging Diseases
